Edgewise Therapeutics, Inc.
USD40.75
-0.17 (-0.41%)
CEO
Kevin Koch
IPO Date
2021-03-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$40.97
Prev. Close
$40.92
Day Low
$40.48
Day High
$41.17
52W Low
$12.30
52W High
$43.93
Market Cap
$4.38B
Volume
0.03M
| -18.4 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -31.4% | -29.5% | 0.02 | 19.50 | -7.0 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -19.5% | -18.4% | 0.01 | 21.53 | -7.1 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -15.6% | -15.0% | 0.00 | 26.97 | -17.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 51.0% | -13.0% | -4.79 | 29.86 | -86.6 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 56.3% | -38.7% | 0.00 | 21.24 | -155.7 |
| -12.7 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -7.3% | -7.0% | 0.01 | 26.51 | -10.5 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -6.1% | -5.9% | 0.01 | 28.87 | -9.5 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -9.5% | -9.0% | 0.01 | 20.99 | -12.8 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -8.6% | -8.1% | 0.01 | 19.93 | -15.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -7.0% | -6.7% | 0.01 | 26.35 | -18.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -6.2% | -5.9% | 0.01 | 30.24 | -14.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -5.3% | -5.2% | 0.01 | 37.08 | -13.8 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -9.5% | -8.9% | 0.02 | 19.50 | -5.9 |